Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/16 → 31/12/20 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$758,319.00
-
Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer
Yip, H. Y. K., Shin, S.-Y., Chee, A., Ang, C. S., Rossello, F. J., Wong, L. H., Nguyen, L. K. & Papa, A., Dec 2024, In: npj Precision Oncology. 8, 1, 21 p., 20.Research output: Contribution to journal › Article › Research › peer-review
Open Access16 Link opens in a new tab Citations (Scopus) -
Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
Yip, H. Y. K. & Papa, A., 16 Mar 2021, In: Cells. 10, 3, 30 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access246 Link opens in a new tab Citations (Scopus) -
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor Suppression
Yip, H. Y. K., Chee, A., Ang, C. S., Shin, S.-Y., Ooms, L. M., Mohammadi, Z., Phillips, W. A., Daly, R. J., Cole, T. J., Bronson, R. T., Nguyen, L. K., Tiganis, T., Hobbs, R. M., McLean, C. A., Mitchell, C. A. & Papa, A., 15 Oct 2020, In: Molecular Cell. 80, 2, p. 279-295.e1-e8 25 p.Research output: Contribution to journal › Article › Research › peer-review
22 Link opens in a new tab Citations (Scopus)